Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharmasset 2Q loss widens on costs
Yahoo/AP
Monday, April 25, 2011 - 9:16am
tags:
earnings, Pharmasset
Botox May Deaden Ability to Empathize, New Study Says
Forbes
Monday, April 25, 2011 - 9:15am
tags:
Botox, Allergan
Eisai Aricept Patch for Alzheimer’s Isn’t Ready for Approval
Bloomberg
Monday, April 25, 2011 - 9:14am
tags:
Eisai, Aricept, Alzheimer's disease, Aricept patch
Johnson & Johnson Looks Promising on New Product Potential
Seeking Alpha
Monday, April 25, 2011 - 9:13am
tags:
JNJ
Pfizer Deal Allows Dr. Reddy’s to Sell Depression Pill in U.S.
Bloomberg
Monday, April 25, 2011 - 9:12am
tags:
Dr Reddy's, Pfizer, Wyeth, generics, Effexor XR, antidepressants
GW Pharma gets US patent for Sativex in cancer pain
pharmabiz
Saturday, April 23, 2011 - 11:18am
tags:
GW Pharma, Sativex, pain management
Baxter's First Quarter Financial Results Exceed Guidance
PharmPro
Saturday, April 23, 2011 - 11:16am
tags:
Baxter International, earnings
Pfizer, Shanghai Pharma sign MoU for potential strategic partnership
pharmabiz
Saturday, April 23, 2011 - 11:15am
tags:
Pfizer, Shanghai Pharmaceutical
GlaxoSmithKline Biologicals looking to acquire Biological E Limited's vaccine division
Invest In India
Saturday, April 23, 2011 - 11:14am
tags:
GSK, Biological E, vaccines
Watson confirms Welchol patent challenge
pharmabiz
Saturday, April 23, 2011 - 11:13am
tags:
Watson Pharmaceuticals, Welchol, Daiichi Sankyo, Genzyme
Biogen Idec's MS Drug Appears to Have an Edge
Motley Fool
Saturday, April 23, 2011 - 11:09am
tags:
Biogen Idec, multiple sclerosis, BG-12, Gelenya, Novartis
Valeant Pharmaceuticals Responds to Cephalon Board's Letter
Bradenton Herald, FL
Saturday, April 23, 2011 - 11:08am
tags:
Valeant Pharmaceuticals, Cephalon, M&A
Regulatory Update - GSK and Valeant Respond to FDA on Ezogabine
PharmaLive
Saturday, April 23, 2011 - 11:06am
tags:
GSK, Valeant Pharmaceuticals, ezogabine, epilepsy
Mylan Launches Generic Version of Famvir® Tablets
PR-USA.net
Saturday, April 23, 2011 - 11:04am
tags:
Mylan, Famvir, Novartis
Dr Reddy’s Settles Patent Dispute With Pfizer’s Unit, PTI Says
Bloomberg
Saturday, April 23, 2011 - 11:01am
tags:
Dr Reddy's, Pfizer, Effexor XR
Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants
PR NewsWire
Saturday, April 23, 2011 - 10:59am
tags:
Sanofi, Menactra, meningococcal conjugate vaccine
Pharma's Most Perilous Pipelines
Motley Fool
Saturday, April 23, 2011 - 10:58am
tags:
Teva Pharmaceuticals, Eli Lilly, Novartis, GSK, AstraZeneca, Pfizer
Pfizer’s Key Drug Walks A Tightrope
Forbes
Saturday, April 23, 2011 - 10:56am
tags:
Pfizer, tofacitinib, rheumatoid arthritis
If Rationing is So Great, Why Does Britain Have Higher Cost Growth Than the U.S.?
Forbes
Saturday, April 23, 2011 - 10:55am
tags:
health care reform
Merck's Risky Bet on Research
Bloomberg
Saturday, April 23, 2011 - 10:51am
tags:
Merck, R&D

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.